Hutchison Chi-Med preps mid-June Hong Kong IPO

Budweiser AB InBev PA 230x150
By Jonathan Breen
11 Jun 2019

Hutchison China MediTech (Chi-Med) is looking to launch bookbuilding for its Hong Kong listing as early as June 21 for proceeds of around $600m, according to a source close to the deal.

The biopharmaceutical company began pre-deal investor education for its IPO on June 6. It is on the road with sponsors Bank of America and Goldman Sachs and global co-ordinators JP Morgan and Morgan Stanley.

Chi-Med is listing through a combined primary and secondary share offering. It is looking ...

Already a subscriber?

Continue reading this article

Try full access to GlobalCapital

Free trial